Sign in

CIK 0000822370

  • Non-accelerated filer
  • Smaller reporting company

Emmaus Life Sciences, Inc.

Sign in to watch
Ticker
EMMA
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870419387
Phone
+1 310-214-0065
Business address
21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
Former names
MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
  1. 4 Grant or award Director acquired 16,000 shares (grant or award)
  2. 4 Open-market buy Director bought 5,000 shares at $6.00 ($30,000)
  3. 4 Grant or award Director acquired 16,000 shares (grant or award)
  4. 4 Grant or award Director acquired 32,000 shares (grant or award)
  5. 4 Grant or award Director acquired 32,000 shares (grant or award)
  6. 4 Other acquisition 10% owner acquired 20,000 shares (other)
  7. 4 Grant or award Director acquired 20,000 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Director acquired 20,000 shares (grant or award)
  11. 4 Grant or award Director acquired 20,000 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award Director acquired 20,000 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Director acquired 40,000 shares (grant or award)
  16. 4 Open-market buy Director bought 200 shares at $8.50 ($1,700)
  17. 4 Open-market buy Director bought 1,000 shares at $8.00 ($8,000)
  18. 4 Open-market buy Director bought 16 shares at $7.50 ($120)
  19. 4 Open-market buy Director bought 1,839 shares at $6.45 ($11,867)
  20. 4 Option exercise 10% owner acquired 137,328 shares (option exercise)

Page 15 of 25 · 488 filings